Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information
Phone(781) 345-9001
DescriptionMedical Device Company


2 Fourth Ave.
Burlington, MA, 01803


CEO, Founder, Chairman of the Board
Chief Financial Officer
Vice President, Marketing
Vice President, Regulatory and Quality Affairs
Senior Vice President, R&D
Senior Vice President, Knee Implant Engineering
Senior Vice President, Intellectual Property & General Counsel
Senior Vice President, Sales


Series D, 8/2009
Aeris Capital
Grant, 7/2011
Series E, 8/2013
Sovereign Wealth Funds
Government Investment Funds




ConforMIS has developed the only line of personalized, partial knee resurfacing implants to treat knee osteoarthritis, one of the most common conditions facing our aging population.

ConforMIS is a privately held medical device company based in Massachusetts. It was founded in 2004 to provide dramatic advancements in patient care by utilizing imaging technology to create personalized, patient-specific implants and instrumentation.

ConforMIS transforms traditional CT and MRI data into patient-specific implants and instrumentation employing two related ‘image-to-implant’ technology platforms. Both platforms are supported by proprietary, intellectual property consisting of more than 250 patents and pending patent applications that span imaging software, image processing, implant design, surgical techniques and orthopedic instrumentation. The technology and patent portfolio is applicable to all major joint systems.

To date, ConforMIS has developed a comprehensive line of minimally traumatic implant solutions to address all stages of knee osteoarthritis, the most common reason for knee replacement surgery. Each of these devices has been cleared for marketing by the US Food and Drug Administration. Certain ConforMIS implants have also received CE Marking for the European region.

Recent Milestones

  • Dollar
    ConforMIS received $168M in Series E funding. (8/2/13)
    Posted 8/4/13 at 8:24pm via
  • Dollar
    ConforMIS received $1.4M in Grant funding. (7/12/11)
    Posted 7/12/11 at 7:50am via
  • Check
    ConforMIS — has received 510k clearance from the U.S. Food and Drug Administration to commercially market its iTotal CR Knee Replacement System (2/3/11)
    Posted 2/7/11 at 5:28am via
  • Dollar
    ConforMIS received $50M in Series D funding. (8/10/09)
    Posted 8/11/09 at 12:52pm via
  • Check
    ConforMIS added David Cerveny as Senior Vice President, Intellectual Property & General Counsel. (10/1/08)
    Posted 11/9/09 at 12:17pm
  • Check
    ConforMIS added Philipp Lang as CEO, Founder, Chairman of the Board. (1/1/04)
    Posted 11/9/09 at 12:15pm
  • Check
    ConforMIS added John Slamin as Senior Vice President, Knee Implant Engineering.
    Posted 11/9/09 at 12:17pm



ConforMIS screenshot
Above: Homepage
Uploaded: 8/5/13


iDuoâ„¢ Bicompartmental Knee Resurfacing Device
iFormaâ„¢ Knee Interpositional Device
iTotalâ„¢ Tricompartmental Knee Resurfacing Device
iUniâ„¢ Unicompartmental Knee Resurfacing Device


  1. ConforMIS, Inc.: Series D $50M ( [edit]
  2. ConforMIS scores $1.4M MassDevelopment loan ( [edit]
  3. ConforMIS raises $167.7m Series E financing ( [edit]
  4. ConforMIS knee replacement tech get FDA marketing nod ( [edit]
Edit This Page
Last Edited 2/20/14

Revision History RSS Picture


Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API


Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy